Latest articles
NICE recommends brigatinib for treating ALK-positive advanced non-small-cell lung cancer
NICE recommends brigatinib for treating ALK-positive advanced non-small-cell lung cancer. Takeda UK Ltd has announced that the National Institute for Health and Care Excellence (NICE)...
NICE recommends pertuzumab for new breast cancer indication
In draft guidance, NICE recommends pertuzumab for new breast cancer indication after improved price offer from Roche.
The National Institute for Health and Care Excellence...
Health matters: preventing cardiovascular disease
The Department of Health and Social Care has published a new professional resource on improving the detection and treatment of the high-risk conditions atrial fibrillation,...